105 related articles for article (PubMed ID: 30366103)
1. Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery.
Harris EJA; Kao S; McCaughan B; Nakano T; Kondo N; Hyland R; Nowak AK; de Klerk NH; Brims FJH
J Thorac Oncol; 2019 Feb; 14(2):288-293. PubMed ID: 30366103
[TBL] [Abstract][Full Text] [Related]
2. A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis.
Brims FJ; Meniawy TM; Duffus I; de Fonseka D; Segal A; Creaney J; Maskell N; Lake RA; de Klerk N; Nowak AK
J Thorac Oncol; 2016 Apr; 11(4):573-82. PubMed ID: 26776867
[TBL] [Abstract][Full Text] [Related]
3. Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion.
Zhang S; Zhang Y; Feng W; Shi Z; Shi H; Zhang Y
Thorac Cancer; 2021 Dec; 12(24):3304-3309. PubMed ID: 34704370
[TBL] [Abstract][Full Text] [Related]
4. Stratification of malignant pleural mesothelioma prognosis using recursive partitioning analysis.
Suzuki H; Asami K; Hirashima T; Okamoto N; Yamadori T; Tamiya M; Morishita N; Shiroyama T; Takeoka S; Osa A; Azuma Y; Okishio K; Kawaguchi T; Atagi S; Kawase I
Lung; 2014 Feb; 192(1):191-5. PubMed ID: 24141556
[TBL] [Abstract][Full Text] [Related]
5. Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions.
Pass HI; Wali A; Tang N; Ivanova A; Ivanov S; Harbut M; Carbone M; Allard J
Ann Thorac Surg; 2008 Jan; 85(1):265-72; discussion 272. PubMed ID: 18154821
[TBL] [Abstract][Full Text] [Related]
6. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
Neragi-Miandoab S; Richards WG; Sugarbaker DJ
Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
[TBL] [Abstract][Full Text] [Related]
7. [Surgical therapy of malignant pleural mesothelioma].
Schirren M; Sponholz S; Oguzhan S; Fisseler-Eckhoff A; Fischer A; Schirren J
Chirurg; 2016 May; 87(5):455-66. PubMed ID: 27169584
[TBL] [Abstract][Full Text] [Related]
8. Improving survival results after surgical management of malignant pleural mesothelioma: an Australian institution experience.
Yan TD; Cao CQ; Boyer M; Tin MM; Kennedy C; McLean J; Bannon PG; McCaughan BC
Ann Thorac Cardiovasc Surg; 2011; 17(3):243-9. PubMed ID: 21697784
[TBL] [Abstract][Full Text] [Related]
9. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery.
Soysal O; Karaoğlanoğlu N; Demiracan S; Topçu S; Taştepe I; Kaya S; Unlü M; Cetin G
Eur J Cardiothorac Surg; 1997 Feb; 11(2):210-3. PubMed ID: 9080144
[TBL] [Abstract][Full Text] [Related]
10. Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group.
Rice D; Rusch V; Pass H; Asamura H; Nakano T; Edwards J; Giroux DJ; Hasegawa S; Kernstine KH; Waller D; Rami-Porta R;
J Thorac Oncol; 2011 Aug; 6(8):1304-12. PubMed ID: 21847060
[TBL] [Abstract][Full Text] [Related]
11. Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma.
Yao ZH; Tian GY; Yang SX; Wan YY; Kang YM; Liu QH; Yao F; Lin DJ
Tumour Biol; 2014 Jul; 35(7):6839-45. PubMed ID: 25051913
[TBL] [Abstract][Full Text] [Related]
12. The C-Reactive Protein/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma: A Retrospective Multi-institutional Study.
Takamori S; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Hirai F; Seto T; Tagawa T; Takenoyama M; Ichinose Y; Maehara Y
Ann Surg Oncol; 2018 Jun; 25(6):1555-1563. PubMed ID: 29500763
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysis.
Ghanim B; Hoda MA; Winter MP; Klikovits T; Alimohammadi A; Hegedus B; Dome B; Grusch M; Arns M; Schenk P; Pohl W; Zielinski C; Filipits M; Klepetko W; Berger W
Ann Surg; 2012 Aug; 256(2):357-62. PubMed ID: 22750759
[TBL] [Abstract][Full Text] [Related]
14. [Survey of surgical treatment of malignant pleural mesothelioma in Japan].
Higashiyama M; Morinaga K
Kyobu Geka; 2007 Jan; 60(1):19-24. PubMed ID: 17249533
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
[TBL] [Abstract][Full Text] [Related]
16. Combination of calretinin, MALAT1, and GAS5 as a potential prognostic biomarker to predict disease progression in surgically treated mesothelioma patients.
Klotz LV; Casjens S; Johnen G; Taeger D; Brik A; Eichhorn F; Förster L; Kaiser N; Muley T; Stolp C; Schneider M; Gleichenhagen J; Brüning T; Winter H; Eichhorn M; Weber DG
Lung Cancer; 2024 Jun; 192():107802. PubMed ID: 38692217
[TBL] [Abstract][Full Text] [Related]
17. Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy.
Batirel HF; Metintas M; Caglar HB; Ak G; Yumuk PF; Yildizeli B; Yuksel M
J Thorac Cardiovasc Surg; 2016 Feb; 151(2):478-84. PubMed ID: 26611742
[TBL] [Abstract][Full Text] [Related]
18. Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies.
Trousse DS; Avaro JP; D'Journo XB; Doddoli C; Astoul P; Giudicelli R; Fuentes PA; Thomas PA
Eur J Cardiothorac Surg; 2009 Oct; 36(4):759-63. PubMed ID: 19523843
[TBL] [Abstract][Full Text] [Related]
19. Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee.
Pass HI; Giroux D; Kennedy C; Ruffini E; Cangir AK; Rice D; Asamura H; Waller D; Edwards J; Weder W; Hoffmann H; van Meerbeeck JP; Rusch VW;
J Thorac Oncol; 2014 Jun; 9(6):856-64. PubMed ID: 24807157
[TBL] [Abstract][Full Text] [Related]
20. [Current status of surgical treatment for malignant pleural mesothelioma].
Hasegawa S
Kyobu Geka; 2011 Jul; 64(8 Suppl):714-8. PubMed ID: 21916183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
